Language: 简体中文 English
重要日期
会议日期

2018年12月15日-12月16日

网上注册截止日期

2018年12月20日

现场报到时间

2018年12月14日

团队代表注册

Ali Mobasheri
     Ali Mobasheri, President-elect of OARSI,University of Surrey, UKAli Mobasheri is Professor of
Musculoskeletal Physiology and Associate Dean for Research and Enterprise inthe Faculty of Health and Medical Sciences at the University of Surrey, UK. His main area of research is cartilage biology and osteoarthritis (OA) biomarkers.He currently co-ordinates the EU FP7 D-BOARD consortium funded by a 5.9 million Euro grant from the European Commission, which brings together leading European academic institutions and SMEs to focus on the identification, validation and qualification of new biomarkers for degenerative and inflammatory diseases of joints. He is also a participating member of the recently launched Applied Public-Private Research enabling OsteoArthritis Clinical Headway (APPROACH)
consortium, which received a 7.5 million Euro grant from the European Commission’s Innovative Medicines Initiative. The overall objective of APPROACH is to phenotype OA patients in order to find the right patient for the right treatment. Ali’s track record of professional achievement is backed up by 180 primary peer-reviewed publications.
       Ali Mobasheri,英国萨里大学骨骼肌肉系统生理学教授, 国际骨关节炎学会 (OARSI)候任主席,目前担任OARSI战略联盟委员会主席。主要研究领域是软骨生物学和骨关节炎(OA)生物标志物。参与协调欧盟FP7 D-BOARD联盟,该联盟由欧洲委员会提供的590万欧元赠款资助,该委员会将欧洲领先的学术机构和中小企业聚集在一起,致力于验证和鉴定退行性和炎症性骨关节炎的新生物标志物,对OA患者进行表型分析,以便找到合适的患者进行正确的治疗。在国际期刊上发表了超过 180 篇研究著作和众多的书籍章节。